Introduction
Schizotypal personality disorder belongs to Cluster A personality disorders, which also include schizoid personality disorder and paranoid personality disorder. Schizotypal personality disorder is characterized by deficits in social and interpersonal skills, highlighted by a reduced ability to form close relationships, occurring in the setting of eccentric behavior and cognitive or perceptual distortions.[1] Symptoms such as restricted affect and social isolation in schizotypal personality disorder may share similarities with those found in schizoid personality and paranoid personality disorders. The symptoms of schizotypal personality disorder must be distinguished from neurodevelopmental disorders, personality changes due to another medical condition, substance use disorders, and other mental disorders with psychotic symptoms.
Schizotypal personality disorder was introduced in the Diagnostic and Statistical Manual of Mental Disorders-III (DSM-III) in 1980. Previously, the diagnosis included a broad spectrum, including both schizotypal and schizoid personality disorders, described as non-psychotic schizophrenia spectrum illnesses.[2] This era of nosology also separated schizotypal personality disorder from borderline personality disorder, which had been vaguely defined.[3] Schizotypal personality disorder has been among the least studied personality disorders, with limited empirical investigations. Personality disorders such as schizotypal, avoidant, schizoid, and borderline personality disorders are associated with considerable decreases in the quality of life.[4] There is a need for further research on these personality disorders.
In the DSM-III, schizotypal personality disorder emerged from a line of investigation studying non-psychotic family members of patients with schizophrenia.[1] Accordingly, schizotypal personality disorder plays a role in the conceptualization of schizophrenia, as the diagnosis of schizotypal personality disorder may be understood in the psychotic versus non-psychotic schizophrenia spectrum. The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR) notes that the course of schizotypal personality disorder is relatively stable, with few individuals developing schizophrenia or another psychotic disorder. In contrast, the World Health Organization reclassified schizotypal personality disorder as a form of schizophrenia in the International Classification of Diseases, 11th Revision (ICD-11).[5]
Etiology
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
When schizotypal personality disorder was introduced in the DSM-III, it was based in part on the study of family members of individuals with schizophrenia. Although older literature suggests that many individuals diagnosed with schizotypal personality disorder progress to schizophrenia, recent research does not support this.[6] There is also disagreement on what constitutes schizotypal personality disorder and its relationship with other Cluster A personality disorders and schizophrenia.
Some common chromosome regions are shared by schizotypal personality disorder and schizophrenia.[6] Among possible candidate genes, the dystrobrevin-binding protein 1 (DTNBP1) gene located on chromosome 6q22.3, which codes for a synaptic protein dysbindin 1, has been associated with schizophrenia and paranoid schizotypy. Functional alterations in the catechol-O-methyltransferase gene (COMT) in the form of a single-nucleotide polymorphism on codon 158, which codes for an enzyme involved in the breakdown of dopamine at the synapse, are believed to contribute to negative and cognitive symptoms in schizophrenia and higher schizotypy scores.[6] According to an older study, platelet monoamine oxidase levels are associated with sociability levels, with low levels occurring in schizotypal personality disorder.[7]
Research on the etiology of schizotypal personality disorder is limited due to the complexity and multifactorial nature of personality disorders. Biological factors contribute to the development of personality through multiple means, with temperament being a heritable and innate psychobiological characteristic that significantly contributes to personality development.[8][9]
Genetic factors have been attributed as significant contributors to the development of a personality disorder; this was supported by multiple studies that investigated twin, linkage, candidate gene association studies, genome-wide association studies, and polygenic analyses.[8] Individuals with Cluster A personality disorders are more likely to have biological relatives with schizophrenia compared to control groups. The association is stronger for schizotypal personality disorder compared to schizoid personality disorder.[10] Schizotypal personality disorder is more prevalent in individuals with first-degree relatives who have schizotypal personality disorder. Hereditability of schizotypy has been estimated between 30% and 50%. Schizotypal traits are also more often found in relatives of those with schizophrenia.[6] Children with major depressive disorder who develop a personality disorder are more likely to develop schizoid, avoidant, borderline, or schizotypal personality disorders compared to other adult personality disorders.[11] In addition, adult prisoners with a childhood history of institutional care had higher scores on schizotypal traits.[12]
Medical conditions are often associated with personality disorders or alterations in personality, specifically those that may damage neurons. Medical conditions include but are not limited to head trauma, cerebrovascular diseases, cerebral tumors, epilepsy, Huntington's disease, multiple sclerosis, endocrine disorders, heavy metal poisoning, neurosyphilis, and AIDS.[13]
Psychoanalytic factors also contribute to the development of personality disorders. Wilhelm Reich, a psychoanalyst, described character armor as defense mechanisms that develop with personality types to relieve cognitive conflict from internal impulses and interpersonal anxiety. For instance, individuals with schizotypal tendencies have withdrawal defense mechanisms.[14]
Personality is a complex summation of biological, psychological, social, and developmental factors. Each individual's personality is unique, even amongst those diagnosed with a personality disorder. Personality is a pattern of behaviors that an individual uniquely adapts to address constantly changing internal and external stimuli. This broader concept is described as temperament, which has heritable and innate psychobiological characteristics.[8][9] Temperament is further shaped through epigenetic mechanisms, including life experiences such as trauma and socioeconomic conditions, which are referred to as adaptive etiological factors in personality development.[15][16] Temperament traits include harm avoidance, novelty seeking, reward dependence, and persistence.
Harm avoidance involves a bias towards inhibiting behavior that results in punishment or non-reward.[17] Individuals with high harm avoidance often experience fear of uncertainty, social inhibition, shy behavior, and avoidance of danger or the unknown, all of which are characteristics of schizotypal personality disorder.
Novelty seeking describes an inherent desire to initiate novel activities likely to produce a reward signal.[18] Schizotypal personality disorder presents with low novelty seeking, resulting in uninquiring, isolative, and stoical behaviors.
Reward dependence describes the amount of desire to alter behaviors in response to social reward cues.[19] Individuals with schizotypal personality typically have low reward dependence and, as a result, spend most of their time in isolation, with little need for social reward compared to individuals without schizotypal personality disorder.
Persistence describes the ability to maintain behaviors despite frustration, fatigue, and limited reinforcement. Low persistence is consistent with schizotypal personality disorder. Low persistence is associated with indolence, inactivity, and ease of frustration. These individuals rarely strive for higher accomplishments.[19][20]
Epidemiology
The prevalence of schizotypal personality disorder is approximately 3.9% worldwide, with men at higher risk (4.2%) compared to women (3.7%).[21] Cluster A personality disorders are common among individuals experiencing homelessness.[22] Quality measures of the prevalence of schizotypal personality disorder are lacking; therefore, these estimates are limited.[23]
Pathophysiology
There are few investigations of neuroimaging and histopathological findings among Cluster A personality disorders. In a study involving 20 research participants with either schizoid personality disorder or schizotypal personality disorder, structural alterations in the pyramidal pathway were observed compared to controls. Specifically, research participants presented with greater bilateral white matter volume in the superior corona radiata adjacent to motor/premotor regions. The hypothesized conclusion from these findings suggests that greater volume in motor pathways might relate to cognitive disorganization and negative symptoms in the schizophrenia spectrum illnesses.[24] According to magnetic resonance imaging, patients with schizophrenia and schizotypal personality disorder may share similarities in altered gross morphology of the insular cortex, suggesting a vulnerability factor associated with early neurodevelopmental anomalies and increased brain gyrification in diverse cortical regions.[25][26] According to a study, patients with schizotypal personality disorder also had a significantly reduced cortical thickness in the left fusiform and parahippocampal gyri, right medial superior frontal gyrus, right inferior frontal gyrus, and right medial orbitofrontal cortex compared to healthy controls.[27][26][25]
History and Physical
Individuals with schizotypal personality disorder often exhibit a diverse range of clinical features. The individuals may appear odd or eccentric, with magical thinking and odd beliefs. Patients may express paranormal, supernatural, or astrological preoccupations. Patients may appear suspicious, hypervigilant, or paranoid, contributing to having difficulty forming close interpersonal relationships, secondary to concern about how others perceive them. The patient should be assessed for any signs of a formal thought disorder, including disorganization, hallucinations, and profound negative symptoms such as apathy, anhedonia, avolition, and alogia. These symptoms may suggest that the patient's presentation is more consistent with a schizophrenia spectrum disorder rather than schizotypal personality disorder.[1]
Inquiring how a patient with suspected schizotypal personality disorder spends their time and who comprises their social circles is essential. Obtaining a detailed social history may provide insight into how the patient's personality disorder impairs their ability to maintain normal social functioning, including educational struggles and difficulty with maintaining employment or obtaining adequate financial resources. In addition to obtaining a detailed social and personal history from the patient, collateral information is essential in diagnosing personality disorders to augment the clinician's view of how an individual reacts to various circumstances over time.[1]
The following factors should be carefully considered in the psychiatric evaluation, including the mental status examination, of individuals suspected of having schizotypal personality disorder.
- Appearance: May appear unkempt, disheveled, or eccentric appearance with odd attire.
- Behavior: May be inappropriate, stiff, peculiar, socially detached, hypervigilant, suspicious, or overtly paranoid.
- Speech: Speech abnormalities include odd, vague, metaphorical, or stereotyped speech. In addition, individuals tend to have more pauses, slower speech, and less pitch variability.
- Affect: Ranges from constricted to expansive and may be inappropriate to the circumstances.
- Thought Content: May be suspicious or have paranoid ideation with magical thinking, fixation on the supernatural or paranormal, odd beliefs, overvalued ideas, or ideas of reference. Suicidal and homicidal ideation should be assessed at each encounter.
- Thought Process: Ranges from logical and goal-directed to vague and rambling, without actual derailment.
- Perceptions: Likely to describe unusual perceptual experiences, including bodily illusions or sensing that another person is present. These experiences are generally not at the level of overt hallucinations, which suggest a schizophrenia spectrum disorder.
- Cognition: General cognition and orientation are not impaired in schizotypal personality disorder. However, assessment is necessary to rule out other psychiatric conditions, such as schizophrenia, where cognitive impairment is common.
Evaluation
The diagnosis of a personality disorder depends on longitudinal observation of a patient's behaviors to understand the patient's long-term functioning. Many characteristics of personality disorders overlap with symptoms of acute psychiatric illness.[28] Therefore, personality disorders should generally be diagnosed when there is not a concurrent acute psychiatric condition. An underlying personality disorder may contribute significantly to hospitalizations or relapse of another psychiatric condition, such as a major depressive episode.[29] The diagnosis of schizotypal personality disorder may take several encounters to be firmly established.
Several psychometric assessments can aid in diagnosing schizotypal personality disorder, including:
- The Schizotypal Personality Questionnaire-Brief
- The Personality Diagnostic Questionnaire-4
- The Personality Inventory for DSM-5 (PID-5)
- The Minnesota Multiphasic Personality Inventory (MMPI)
Of these psychometric tools, the Schizotypal Personality Questionnaire-Brief has shown the best internal consistency with a reported alpha coefficient of 0.87.[30]
According to a study, the MMPI was able to cluster schizotypal personality disorder and schizophrenia together accurately more than 90% of the time. However, both clinical entities have significant overlap. The Personality Diagnostic Questionnaire-4 is a good screening tool for personality disorders in general but is not specific to schizotypal personality disorder. In a study, the Personality Inventory for DSM-5 (PID-5) reported a kappa coefficient of 0.5, indicating moderate agreement on the diagnosis of schizotypal personality disorder.[30]
When assessing an individual for schizotypal personality disorder, it is important to consider cultural factors when applying diagnostic criteria. According to the DSM-5-TR, beliefs such as life beyond death, speaking in tongues, voodoo, shamanism, mind reading, sixth sense, evil eye, magical beliefs related to health and illness, and other culture-related issues must be considered when evaluating cognitive and perceptual distortions.
DSM-5-TR Diagnostic Criteria for Schizotypal Personality Disorder
A pervasive pattern of social and interpersonal deficits characterized by acute discomfort with, and reduced capacity for, close relationships, as well as cognitive or perceptual distortions and eccentricities of behavior, typically beginning in early adulthood and present in a variety of contexts, as indicated by 5 (or more) of the following:
- Ideas of reference (excluding delusions of reference).
- Odd beliefs or magical thinking that influence behavior and are inconsistent with subcultural norms, such as superstitious, belief in clairvoyance, telepathy, or sixth sense; in children and adolescents, bizarre fantasies or preoccupations.
- Unusual perceptual experiences, including bodily illusions.
- Odd thinking and speech, such as vague, circumstantial, metaphorical, overelaborate, or stereotyped.
- Suspiciousness or paranoid ideation.
- Inappropriate or constricted affect.
- Behavior or appearance that is odd, eccentric, or peculiar.
- Lack of close friends or confidants other than first-degree relatives.
- Excessive social anxiety does not diminish with familiarity and tends to be associated with paranoid fears rather than negative judgments about self.
Does not occur exclusively during the course of schizophrenia, a bipolar disorder or depressive disorder with psychotic characteristics, another psychotic disorder, or autism spectrum disorder.
If criteria are met prior to the onset of schizophrenia, premorbid can be added, for example, schizotypal personality disorder (premorbid).
The DSM-5-TR introduced an alternative diagnostic model for personality disorders in the Emerging Measures and Models section. The alternative diagnostic model for personality disorders in the DSM-5-TR is a hybrid dimensional-categorical model that defines personality disorders in terms of impairments in personality functioning and pathological personality traits.[31]
DSM-5-TR Alternative Diagnostic Model for Schizotypal Personality Disorder
The DSM-5-TR alternative diagnostic model for schizotypal personality disorder outlines two main criteria—Criterion A and Criterion B.
Criterion A: This criterion denotes a requirement for moderate or greater impairment in personality functioning. Individuals must demonstrate significant challenges in 2 or more of the following 4 areas.
- Identity: Confused boundaries between self and others; distorted self-concept; emotional expression often not congruent with context or internal experience.
- Self-direction: Unrealistic or incoherent goals; no clear set of internal standards.
- Empathy: Pronounced difficulty understanding the impact of own behaviors on others; frequent misinterpretations of others' motivations and behaviors.
- Intimacy: Marked impairments in developing close relationships associated with mistrust and anxiety.
Criterion B: This criterion outlines 6 pathological personality traits, and diagnosis requires 4 or more of these traits.
- Cognitive and perceptual dysregulation (an aspect of psychoticism): Odd or unusual thought processes; vague, circumstantial, metaphorical, overelaborate, or stereotyped thought or speech; odd sensations in various sensory modalities.
- Unusual beliefs and experiences (an aspect of psychoticism): Thought content and views of reality that are viewed by others as bizarre or idiosyncratic; unusual experiences of reality.
- Eccentricity (an aspect of psychoticism): Odd, unusual, or bizarre behavior or appearance; saying unusual or inappropriate things.
- Restricted affectivity (an aspect of detachment): Little reaction to emotionally arousing situations; constricted emotional experience and expression; indifference or coldness.
- Withdrawal (an aspect of detachment): Preference for being alone to being with others; reticence in social situations; avoidance of social contacts and activity; lack of initiation of social contact.
- Suspiciousness (an aspect of detachment): Expectations of, and heightened sensitivity to, signs of interpersonal ill-intent or harm; doubts about loyalty and fidelity of others; feelings of persecution.
Treatment / Management
Limited evidence-based treatments are available for schizotypal personality disorder, partly due to changes in diagnosis over time and the inclusion of patients with schizotypal personality disorder and comorbid conditions in some studies. There are no medications approved by the Food and Drug Administration; the studies of pharmacotherapy showed that antipsychotic medications were the most commonly used drugs. There is insufficient evidence to recommend any particular psychotherapy treatment for schizotypal personality disorder.[30] Although psychotherapy has shown some promise in helping individuals with this disorder, the existing studies are often underpowered and not randomized. Efficacy has been reported for antidepressants and antipsychotics to help with specific symptoms of schizotypical personality disorder. In particular, second-generation antipsychotics have shown promise in addressing paranoid ideation; however, it is important to note that treatment decisions should be made on a case-by-case basis.[32](A1)
Individuals with schizotypal personality disorder may not recognize their illness and commonly present at the behest of a first-degree relative. Generally, this occurs after maladaptive behaviors have created stress on another rather than internal distress on the part of the individual with schizotypal personality disorder. Therefore, it is essential to assess the goals of treatment in each case of schizotypal personality disorder. As schizotypal personality disorder is unlikely to remit with or without treatment, the focus of treatment may be aimed at reducing interpersonal conflict and stabilizing socioeconomic conditions.[1]
Differential Diagnosis
The differential diagnosis of schizotypal personality disorder is broad. The disorder must be differentiated from schizophrenia, and, as noted in the DSM-5-TR, if the patient proceeds to develop a schizophrenia spectrum disorder, the diagnosis of schizotypal personality disorder must be recorded with the qualifier of premorbid. Schizotypal personality disorder belongs to the Cluster A personality disorders, which are all believed to exist in the psychotic spectrum without formally being psychotic disorders.[1] If a patient meets the criteria for more than 1 personality disorder, all disorders can be diagnosed accordingly. According to the DSM-5-TR, schizotypal personality disorder can be distinguished from other psychiatric disorders as described below.
Delusional disorder, schizophrenia, and mood disorders with psychotic features are all characterized by a period of persistent psychotic symptoms such as delusions and hallucinations. Individuals with schizotypal personality disorder can present with perceptual distortions and ideas of reference, such as believing that an external event was specifically about them. However, they do not have delusions of reference, which are held with absolute conviction.
Schizotypal personality disorder presents with eccentricities and cognitive or perceptual distortions, whereas these symptoms are absent in schizoid personality disorder and paranoid personality disorder.
Schizotypal personality disorder and neurodevelopmental disorders, such as mild autism spectrum disorders or language communication disorders, share deficits in social reciprocity, emotional functioning, and peculiar speech and behaviors. The presence of magical thinking, perceptual abnormalities, and ideas of reference is more consistent with schizotypal personality disorder. Autism spectrum disorder shows an even greater lack of social awareness, emotional reciprocity, and stereotyped behaviors and interests compared to schizotypal personality disorder.
Personality change due to another medical condition and persistent substance use disorders must be distinguished from schizotypal personality disorder. Medical conditions are often associated with personality disorders or changes, specifically including those with pathology that may damage neurons. Medical conditions include, but are not limited to, head trauma, cerebrovascular diseases, cerebral tumors, epilepsy, Huntington's disease, multiple sclerosis, endocrine disorders, heavy metal poisoning, neurosyphilis, and AIDS.[13]
Pertinent Studies and Ongoing Trials
Few studies have been published on schizotypal personality disorder since the DSM-III in 1980. In the new era of DSM-5-TR and the ever-shifting social landscape, detailed case reports and case series that highlight how schizotypal personality disorder manifests in modern clinical practice are needed.
In the DSM-5-TR, personality disorders are grouped into 3 clusters based on shared characteristics, referred to as Cluster A, Cluster B, and Cluster C. Cluster A refers to personality disorders with odd or eccentric characteristics, including paranoid personality disorder, schizoid personality disorder, and schizotypal personality disorder.[33] Cluster B refers to personality disorders with dramatic, emotional, or erratic characteristics, including antisocial personality disorder, borderline personality disorder, histrionic personality disorder, and narcissistic personality disorder.[34] Cluster C refers to personality disorders with anxious and fearful characteristics, including avoidant personality disorder, dependent personality disorder, and obsessive-compulsive personality disorder.[35] Despite the historical use of the cluster system, there are limitations when approaching personality disorders in this manner, and the 3 groupings are not consistently validated in the literature.[36]
Despite behavioral patterns that have been classified into syndromes or personality disorders, the uniqueness of each individual remains problematic for diagnosing and researching specific personality disorders.[36] Experts in personality disorders have suggested switching to a dimensional model of personality rather than continuing to use a cluster model. The proposed dimensional models generally describe temperament, utilization of defense mechanisms, and identification of pathological personality traits.[37] To provide an alternative, the DSM-5-TR added a section with a hybrid dimensional-categorical model to address the shortcomings of the current classifications. As evolving research informs clinical guidelines, the paradigm is likely to undergo a shift in the coming decades.
In addition, new notions of schizotypy have emerged, employing a network approach to conceptualize the disorder as a complex dynamic system.[38]
Prognosis
Schizotypal personality disorder has a relatively stable course, and only a few individuals progress to schizophrenia or another psychotic disorder. Individuals with schizotypal personality disorder are less likely to achieve educational goals or employment.[39] Given the difficulties with interpersonal relationships, they are also less likely to form long-term commitments or have children.[40] Women are more likely to exhibit magical thinking and express interest in topics such as the paranormal.[41][42][43] Men are more likely to have severe cognitive deficits.[44]
Complications
Schizotypal personality disorder can lead to many potential complications, including an increased risk of substance use, self-harm, and hospitalization.[45][46][47] In some cases, patients may progress to a formal thought disorder such as schizophrenia. Other personality disorders may be comorbid with schizotypal personality disorder, most commonly paranoid, schizoid, borderline, and avoidant personality disorders. Substance use disorders are common among personality disorders, but there is limited evidence on which personality disorders pose the most risk for a substance use disorder.[48] Individuals with personality disorders have an increased likelihood of suicide and suicide attempts compared to those without personality disorders, and individuals with schizotypal personality disorder should be screened regularly for suicidal ideation.[49]
Deterrence and Patient Education
The effective treatment of schizotypal personality disorder relies on developing and maintaining a therapeutic rapport. Patients should be encouraged to articulate any symptoms they wish to address or any psychosocial stressors the treatment team can help alleviate. If the patient is not in clinical distress from these symptoms, clinicians should refrain from focusing on reducing symptoms and instead focus on optimizing the patient's strengths. Encouraging patients to utilize support networks through any social relationships is desirable. Involving the patient's family can aid in monitoring for any signs of decompensation. Therapists can educate the patient and their family about ways to stabilize the patient's living situation.[50] Utilizing standardized assessments for the quality of life may reveal ways to optimize the patient's ability to function.[4]
Enhancing Healthcare Team Outcomes
The diagnosis and treatment of schizotypal personality disorder is complicated and ultimately an area open for psychiatric research. As diagnostic models shift away from a cluster system and towards a dimensional model of personality disorders, the implications for clinical practice are unclear. When a treatment team suspects that an individual has schizotypal personality disorder, a thorough psychiatric evaluation, including a detailed history in conjunction with collateral information, is recommended before formally diagnosing patients with schizotypal personality disorder. The treatment team should educate family members about monitoring individuals with schizotypal personality disorder for any positive symptoms of psychosis, such as delusions or hallucinations, that may indicate the development of schizophrenia.[50]
Including the patient's perspective and collaborating with them in determining the appropriate goals of care are important to prevent overmedicalization or iatrogenic harm to patients not experiencing treatable symptoms. Collaborative efforts involving psychologists, psychiatrists, social workers, psychiatric-mental health nurse practitioners, psychiatric nurses, primary care practitioners, and family members can help optimize the psychosocial factors of a patient's life, offering stability to individuals with schizotypal personality disorder. Treatment teams encountering cases of schizotypal personality should consider publishing detailed case descriptions (Oxford CEBM evidence level 5), along with the treatments and psychosocial factor optimizations attempted and their outcomes.
References
Rosell DR, Futterman SE, McMaster A, Siever LJ. Schizotypal personality disorder: a current review. Current psychiatry reports. 2014 Jul:16(7):452. doi: 10.1007/s11920-014-0452-1. Epub [PubMed PMID: 24828284]
Triebwasser J, Chemerinski E, Roussos P, Siever LJ. Schizoid personality disorder. Journal of personality disorders. 2012 Dec:26(6):919-26. doi: 10.1521/pedi.2012.26.6.919. Epub [PubMed PMID: 23281676]
Spitzer RL, Endicott J. Justification for separating schizotypal and borderline personality disorders. Schizophrenia bulletin. 1979:5(1):95-104 [PubMed PMID: 441693]
Cramer V, Torgersen S, Kringlen E. Personality disorders and quality of life. A population study. Comprehensive psychiatry. 2006 May-Jun:47(3):178-84 [PubMed PMID: 16635645]
Level 2 (mid-level) evidenceBach B, First MB. Application of the ICD-11 classification of personality disorders. BMC psychiatry. 2018 Oct 29:18(1):351. doi: 10.1186/s12888-018-1908-3. Epub 2018 Oct 29 [PubMed PMID: 30373564]
Walter EE, Fernandez F, Snelling M, Barkus E. Genetic Consideration of Schizotypal Traits: A Review. Frontiers in psychology. 2016:7():1769 [PubMed PMID: 27895608]
Reist C, Haier RJ, DeMet E, Chicz-DeMet A. Platelet MAO activity in personality disorders and normal controls. Psychiatry research. 1990 Sep:33(3):221-7 [PubMed PMID: 2243899]
Sanchez-Roige S, Gray JC, MacKillop J, Chen CH, Palmer AA. The genetics of human personality. Genes, brain, and behavior. 2018 Mar:17(3):e12439. doi: 10.1111/gbb.12439. Epub 2017 Dec 29 [PubMed PMID: 29152902]
Réale D, Reader SM, Sol D, McDougall PT, Dingemanse NJ. Integrating animal temperament within ecology and evolution. Biological reviews of the Cambridge Philosophical Society. 2007 May:82(2):291-318 [PubMed PMID: 17437562]
Level 3 (low-level) evidenceNigg JT, Goldsmith HH. Genetics of personality disorders: perspectives from personality and psychopathology research. Psychological bulletin. 1994 May:115(3):346-80 [PubMed PMID: 8016285]
Level 3 (low-level) evidenceRamklint M, von Knorring AL, von Knorring L, Ekselius L. Child and adolescent psychiatric disorders predicting adult personality disorder: a follow-up study. Nordic journal of psychiatry. 2003:57(1):23-8 [PubMed PMID: 12745785]
Yang M, Ullrich S, Roberts A, Coid J. Childhood institutional care and personality disorder traits in adulthood: findings from the British national surveys of psychiatric morbidity. The American journal of orthopsychiatry. 2007 Jan:77(1):67-75 [PubMed PMID: 17352587]
Level 3 (low-level) evidenceLeppla I, Fishman D, Kalra I, Oldham MA. Clinical Approach to Personality Change Due to Another Medical Condition. Journal of the Academy of Consultation-Liaison Psychiatry. 2021 Jan-Feb:62(1):14-21. doi: 10.1016/j.psym.2020.08.003. Epub 2020 Sep 12 [PubMed PMID: 33190792]
Shapiro D. Theoretical reflections on Wilhelm Reich's Character Analysis. American journal of psychotherapy. 2002:56(3):338-46 [PubMed PMID: 12400201]
Svrakic DM, Cloninger RC. Epigenetic perspective on behavior development, personality, and personality disorders. Psychiatria Danubina. 2010 Jun:22(2):153-66 [PubMed PMID: 20562740]
Level 3 (low-level) evidenceGescher DM, Kahl KG, Hillemacher T, Frieling H, Kuhn J, Frodl T. Epigenetics in Personality Disorders: Today's Insights. Frontiers in psychiatry. 2018:9():579. doi: 10.3389/fpsyt.2018.00579. Epub 2018 Nov 19 [PubMed PMID: 30510522]
Wan L, Zha R, Ren J, Li Y, Zhao Q, Zuo H, Zhang X. Brain morphology, harm avoidance, and the severity of excessive internet use. Human brain mapping. 2022 Jul:43(10):3176-3183. doi: 10.1002/hbm.25842. Epub 2022 Mar 25 [PubMed PMID: 35332975]
Gocłowska MA, Ritter SM, Elliot AJ, Baas M. Novelty seeking is linked to openness and extraversion, and can lead to greater creative performance. Journal of personality. 2019 Apr:87(2):252-266. doi: 10.1111/jopy.12387. Epub 2018 Jun 11 [PubMed PMID: 29604214]
Frank GKW, Shott ME, Sternheim LC, Swindle S, Pryor TL. Persistence, Reward Dependence, and Sensitivity to Reward Are Associated With Unexpected Salience Response in Girls but Not in Adult Women: Implications for Psychiatric Vulnerabilities. Biological psychiatry. Cognitive neuroscience and neuroimaging. 2022 Nov:7(11):1170-1182. doi: 10.1016/j.bpsc.2021.04.005. Epub 2021 Apr 17 [PubMed PMID: 33872764]
McGiboney GW, Carter C. Measuring persistence and personality characteristics of adolescents. Psychological reports. 1993 Feb:72(1):128-30 [PubMed PMID: 8451343]
Pulay AJ, Stinson FS, Dawson DA, Goldstein RB, Chou SP, Huang B, Saha TD, Smith SM, Pickering RP, Ruan WJ, Hasin DS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. Primary care companion to the Journal of clinical psychiatry. 2009:11(2):53-67 [PubMed PMID: 19617934]
Level 3 (low-level) evidenceConnolly AJ, Cobb-Richardson P, Ball SA. Personality disorders in homeless drop-in center clients. Journal of personality disorders. 2008 Dec:22(6):573-88. doi: 10.1521/pedi.2008.22.6.573. Epub [PubMed PMID: 19072678]
Torgersen S. The nature (and nurture) of personality disorders. Scandinavian journal of psychology. 2009 Dec:50(6):624-32. doi: 10.1111/j.1467-9450.2009.00788.x. Epub [PubMed PMID: 19930262]
Via E, Orfila C, Pedreño C, Rovira A, Menchón JM, Cardoner N, Palao DJ, Soriano-Mas C, Obiols JE. Structural alterations of the pyramidal pathway in schizoid and schizotypal cluster A personality disorders. International journal of psychophysiology : official journal of the International Organization of Psychophysiology. 2016 Dec:110():163-170. doi: 10.1016/j.ijpsycho.2016.08.006. Epub 2016 Aug 14 [PubMed PMID: 27535345]
Takahashi T, Sasabayashi D, Takayanagi Y, Furuichi A, Kobayashi H, Yuasa Y, Noguchi K, Suzuki M. Gross anatomical features of the insular cortex in schizophrenia and schizotypal personality disorder: Potential relationships with vulnerability, illness stages, and clinical subtypes. Frontiers in psychiatry. 2022:13():1050712. doi: 10.3389/fpsyt.2022.1050712. Epub 2022 Nov 18 [PubMed PMID: 36465304]
Sasabayashi D, Takayanagi Y, Takahashi T, Nemoto K, Furuichi A, Kido M, Nishikawa Y, Nakamura M, Noguchi K, Suzuki M. Increased brain gyrification in the schizophrenia spectrum. Psychiatry and clinical neurosciences. 2020 Jan:74(1):70-76. doi: 10.1111/pcn.12939. Epub 2019 Nov 2 [PubMed PMID: 31596011]
Takayanagi Y, Sasabayashi D, Takahashi T, Furuichi A, Kido M, Nishikawa Y, Nakamura M, Noguchi K, Suzuki M. Reduced Cortical Thickness in Schizophrenia and Schizotypal Disorder. Schizophrenia bulletin. 2020 Feb 26:46(2):387-394. doi: 10.1093/schbul/sbz051. Epub [PubMed PMID: 31167030]
Clark LA. Assessment and diagnosis of personality disorder: perennial issues and an emerging reconceptualization. Annual review of psychology. 2007:58():227-57 [PubMed PMID: 16903806]
Campbell K, Clarke KA, Massey D, Lakeman R. Borderline Personality Disorder: To diagnose or not to diagnose? That is the question. International journal of mental health nursing. 2020 Oct:29(5):972-981. doi: 10.1111/inm.12737. Epub 2020 May 19 [PubMed PMID: 32426937]
Kirchner SK, Roeh A, Nolden J, Hasan A. Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review. NPJ schizophrenia. 2018 Oct 3:4(1):20. doi: 10.1038/s41537-018-0062-8. Epub 2018 Oct 3 [PubMed PMID: 30282970]
Level 1 (high-level) evidenceKwapil TR, Barrantes-Vidal N. Schizotypal personality disorder in the alternative model for personality disorders. Personality disorders. 2022 Jul:13(4):392-396. doi: 10.1037/per0000538. Epub [PubMed PMID: 35787127]
Koch J, Modesitt T, Palmer M, Ward S, Martin B, Wyatt R, Thomas C. Review of pharmacologic treatment in cluster A personality disorders. The mental health clinician. 2016 Mar:6(2):75-81. doi: 10.9740/mhc.2016.03.75. Epub 2016 Mar 8 [PubMed PMID: 29955451]
Esterberg ML, Goulding SM, Walker EF. Cluster A Personality Disorders: Schizotypal, Schizoid and Paranoid Personality Disorders in Childhood and Adolescence. Journal of psychopathology and behavioral assessment. 2010 Dec 1:32(4):515-528 [PubMed PMID: 21116455]
Turner D, Sebastian A, Tüscher O. Impulsivity and Cluster B Personality Disorders. Current psychiatry reports. 2017 Mar:19(3):15. doi: 10.1007/s11920-017-0768-8. Epub [PubMed PMID: 28251591]
Massaal-van der Ree LY, Eikelenboom M, Hoogendoorn AW, Thomaes K, van Marle HJF. Cluster B versus Cluster C Personality Disorders: A Comparison of Comorbidity, Suicidality, Traumatization and Global Functioning. Behavioral sciences (Basel, Switzerland). 2022 Apr 12:12(4):. doi: 10.3390/bs12040105. Epub 2022 Apr 12 [PubMed PMID: 35447677]
Tackett JL, Silberschmidt AL, Krueger RF, Sponheim SR. A dimensional model of personality disorder: incorporating DSM Cluster A characteristics. Journal of abnormal psychology. 2008 May:117(2):454-9. doi: 10.1037/0021-843X.117.2.454. Epub [PubMed PMID: 18489222]
Trull TJ, Widiger TA. Dimensional models of personality: the five-factor model and the DSM-5. Dialogues in clinical neuroscience. 2013 Jun:15(2):135-46 [PubMed PMID: 24174888]
Fonseca-Pedrero E, Debbané M, Rodríguez-Testal JF, Cohen AS, Docherty AR, Ortuño-Sierra J. Schizotypy: The Way Ahead. Psicothema. 2021 Feb:33(1):16-27. doi: 10.7334/psicothema2019.285. Epub [PubMed PMID: 33453732]
McGurk SR, Mueser KT, Mischel R, Adams R, Harvey PD, McClure MM, Look AE, Leung WW, Siever LJ. Vocational functioning in schizotypal and paranoid personality disorders. Psychiatry research. 2013 Dec 15:210(2):498-504. doi: 10.1016/j.psychres.2013.06.019. Epub 2013 Aug 8 [PubMed PMID: 23932840]
Dickey CC, McCarley RW, Niznikiewicz MA, Voglmaier MM, Seidman LJ, Kim S, Shenton ME. Clinical, cognitive, and social characteristics of a sample of neuroleptic-naive persons with schizotypal personality disorder. Schizophrenia research. 2005 Oct 15:78(2-3):297-308 [PubMed PMID: 15985362]
Raine A. Sex differences in schizotypal personality in a nonclinical population. Journal of abnormal psychology. 1992 May:101(2):361-4 [PubMed PMID: 1583234]
Denovan A, Dagnall N, Drinkwater K, Parker A. Latent Profile Analysis of Schizotypy and Paranormal Belief: Associations with Probabilistic Reasoning Performance. Frontiers in psychology. 2018:9():35. doi: 10.3389/fpsyg.2018.00035. Epub 2018 Jan 26 [PubMed PMID: 29434562]
Kulkarni J. Estrogen - A key neurosteroid in the understanding and treatment of mental illness in women. Psychiatry research. 2023 Jan:319():114991. doi: 10.1016/j.psychres.2022.114991. Epub 2022 Nov 28 [PubMed PMID: 36502712]
Level 3 (low-level) evidenceVoglmaier MM, Seidman LJ, Niznikiewicz MA, Dickey CC, Shenton ME, McCarley RW. A comparative profile analysis of neuropsychological function in men and women with schizotypal personality disorder. Schizophrenia research. 2005 Apr 1:74(1):43-9 [PubMed PMID: 15694753]
Level 2 (mid-level) evidenceEsterberg ML, Goulding SM, McClure-Tone EB, Compton MT. Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample. Addictive behaviors. 2009 Apr:34(4):374-9. doi: 10.1016/j.addbeh.2008.11.007. Epub 2008 Nov 21 [PubMed PMID: 19136217]
Sher L. Schizotypal personality disorder and suicide: problems and perspectives. Acta neuropsychiatrica. 2021 Oct:33(5):280-282. doi: 10.1017/neu.2021.19. Epub 2021 Jul 8 [PubMed PMID: 34233771]
Level 3 (low-level) evidenceBornstein RF, Klein DN, Mallon JC, Slater JF. Schizotypal personality disorder in an outpatient population: incidence and clinical characteristics. Journal of clinical psychology. 1988 May:44(3):322-5 [PubMed PMID: 3384958]
Parmar A, Kaloiya G. Comorbidity of Personality Disorder among Substance Use Disorder Patients: A Narrative Review. Indian journal of psychological medicine. 2018 Nov-Dec:40(6):517-527. doi: 10.4103/IJPSYM.IJPSYM_164_18. Epub [PubMed PMID: 30533947]
Level 3 (low-level) evidenceAttademo L, Bernardini F, Spatuzzi R. Suicidality in Individuals with Schizoid Personality Disorder or Traits: A Clinical Mini-Review of a Probably Underestimated Issue. Psychiatria Danubina. 2021 Fall:33(3):261-265. doi: 10.24869/psyd.2021.261. Epub [PubMed PMID: 34795159]
Kotlicka-Antczak M, Karbownik MS, Pawełczyk A, Żurner N, Pawełczyk T, Strzelecki D, Urban-Kowalczyk M. A developmentally-stable pattern of premorbid schizoid-schizotypal features predicts psychotic transition from the clinical high-risk for psychosis state. Comprehensive psychiatry. 2019 Apr:90():95-101. doi: 10.1016/j.comppsych.2019.02.003. Epub 2019 Feb 16 [PubMed PMID: 30831438]